Connection

RAVIKUMAR JIMMIDI to Humans

This is a "connection" page, showing publications RAVIKUMAR JIMMIDI has written about Humans.
Connection Strength

0.055
  1. Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology. Proc Natl Acad Sci U S A. 2024 Nov 19; 121(47):e2413108121.
    View in: PubMed
    Score: 0.024
  2. Reversible male contraception by targeted inhibition of serine/threonine kinase 33. Science. 2024 05 24; 384(6698):885-890.
    View in: PubMed
    Score: 0.006
  3. Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection. Nat Commun. 2022 05 10; 13(1):2564.
    View in: PubMed
    Score: 0.005
  4. Pillar[5]arene-Based Polycationic Glyco[2]rotaxanes Designed as Pseudomonas aeruginosa Antibiofilm Agents. J Med Chem. 2021 10 14; 64(19):14728-14744.
    View in: PubMed
    Score: 0.005
  5. DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
    View in: PubMed
    Score: 0.005
  6. A Small-Molecule Inhibitor of Bax and Bak Oligomerization Prevents Genotoxic Cell Death and Promotes Neuroprotection. Cell Chem Biol. 2017 Apr 20; 24(4):493-506.e5.
    View in: PubMed
    Score: 0.004
  7. Selected hybrid natural products as tubulin modulators. Eur J Med Chem. 2015 Apr 13; 94:497-508.
    View in: PubMed
    Score: 0.003
  8. Small molecule modulators of protein-protein interactions: selected case studies. Chem Rev. 2014 May 14; 114(9):4640-94.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.